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Capsule: Ovarian tissue cryopreservation (OTC) may be considered in girls and young women 30 
with Turner syndrome, however the benefit may be limited to a highly selected group of TS 31 
mosaic patients. 32 
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Abstract 34 
 35 
Objective: To characterize ovarian follicles of girls and young women with Turner syndrome 36 
(TS) who underwent ovarian tissue cryopreservation (OTC).  37 
Design: Retrospective case-control study. 38 
Setting: University hospital. 39 
Patients/Animals: 15 girls and young women with TS aged 5-22 years at OTC were included 40 
together with 42  control girls and young women aged 1-25 years who underwent OTC due to 41 
cancer. 42 
Intervention(s): None 43 
Main Outcome Measure(s): Follicle density (follicles/mm3), morphology and health were 44 
assessed in ovarian cortex biopsies from TS patients and compared to control ovaries. Hormone 45 
concentrations were measured in blood samples and follicle fluid samples. Immature cumulus 46 
oocyte complexes (COCs) were obtained and matured in vitro.    47 
Results: Follicles were found in 60% (9/15) of the biopsies from TS ovaries. In 78% (7/9) of 48 
the ovaries with follicles, the follicle density was within the 95% CI of the control group. There 49 
was a high rate of abnormal follicle morphology. 6 follicle specific proteins were expressed 50 
similarly in TS and control ovaries. However, markers of apoptosis and zona pellucida were 51 
found to be abnormal in TS. TS follicle fluid from small antral follicles had lower 52 
concentrations of estrogen and testosterone and higher concentrations of AMH than controls 53 
(p=0.036, 0.001, 0.005, respectively). 31 COCs were collected from one patient and cultured 54 
for 48 hours in vitro, resulting in 5 MII oocytes (maturation rate 16%, degeneration rate 19%).    55 
Conclusion: The benefits of OTC may be limited to a highly selected group of TS mosaic 56 
patients in whom a sizeable pool of normal follicles is present at OTC. 57 
Keywords: Turner syndrome, follicle density, ovarian tissue cryopreservation  58 
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Introduction 59 
Turner syndrome (TS) is caused by the absence of one of the two X chromosomes in all cells 60 
or a proportion of cells, affecting approximately 1:2000 Caucasian girls (1). The most common 61 
karyotype is 45,X (47%), followed by different mosaicisms, most commonly 45,X/46,XX 62 
(17%). The main reproductive effect of TS is Primary Ovarian Insufficiency (POI) (2,3). 63 
Although menarche occurs spontaneously in 15-30% of TS girls the prevalence of natural 64 
pregnancy is as little as 2-7% (2–6).  65 
 66 
Two previous studies have reported the presence of ovarian follicles in 15/47 (7) and in 8/9 (8) 67 
adolescent TS patients. Mosaicism and spontaneous menarche were predictive for the presence 68 
of follicles, consistent with pregnancy being most prevalent in women with mosaic TS (2,5), 69 
and ovarian tissue cryopreservation (OTC) has been suggested as an option for fertility 70 
preservation (7). Predictors for the presence of ovaries without follicles in TS girls include 71 
karyotype 45,X, low serum AMH, high serum FSH, and absent menarche or puberty (7,8). 72 
Oocyte donation is the only way for TS patients with POI to conceive, but pregnancies carry a 73 
substantial risk to mother and fetus (6,9,10).  74 
The aim of this study was to characterize the number and morphology of follicles in girls and 75 
young women with TS, who underwent OTC. We have also evaluated follicle and oocyte 76 
function to assess the potential for future fertility restoration in order to evaluate whether or not 77 
to perform OTC in this group of patients.  78 
 79 
Material and Methods 80 
Patients and ovarian tissue cryopreservation  81 
A total of 15 girls and young women with TS aged 5.0-22.4 years (mean age 15.4 years) were 82 
included together with 42 control girls and young women aged 1.5-25.5 years (mean age 15.2 83 
years). The control group were referred to the Danish program for fertility preservation by OTC 84 
because of a cancer diagnosis and have not revived any gonadotoxic treatment before OTC. 85 
Patients from both groups were only included if an ovarian cortex biopsy was spared for 86 
histology in connection with OTC. All patients underwent OTC between the years 2002 and 87 
2016. Follicle densities in the control girls with cancer below tha age of 18 years has previously 88 
been published (11). One additional ovarian biopsy from a girl with Fanconi anemia was 89 
included for immunohistochemical (IHC) staining. During the preparation of ovarian tissue, 90 
two patients presented with visible antral follicles on the ovarian surface from which follicle 91 
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fluid from a total of 8 small antral follicles was collected. In one of these patients additionally 92 
a total of 31 cumulus oocyte complexes (COCs) were obtained from the medulla tissue. Patient 93 
characteristics are given in Table 1; there were 7 in the Danish cohort, 5 from UK and 3 from 94 
Australia. All controls were age matched patients having OTC for conditions other than TS in 95 
Denmark. The ovarian cortex was prepared as previously described for slow-freezing (12,13) 96 
and stored in liquid nitrogen. Additionally, one small piece of cortex (≤ 2x2x1 mm) was 97 
obtained for histological examination. The OTC schemes were approved by the ethics 98 
committee of Copenhagen and Frederiksberg (H-2-2001-044) and Lothian Health (ref 99 
06/S1103/26). The storage and collection of patient data were approved by the Ministry of 100 
Health (J. no. 30-1372) and by the Danish authorities to comply with European Union tissue 101 
directives. All participants, or parents for younger patients, gave informed consent in writing. 102 
 103 
Tissue processing 104 
Tissues from Edinburgh (subjects 1, 3, 9, 13, and 14) were fixed in 10% neutral buffered 105 
formalin (NBF); tissues from Melbourne (subjects 7, 8, and 11) were fixed in 4% 106 
paraformaldehyde, whereas the remaining tissues from Copenhagen were fixed in Bouin’s 107 
solution. In Edinburgh and Melbourne 5 or 6 µm sections of paraffin embedded human ovarian 108 
cortex were prepared, de-waxed and stained with haematoxylin and eosin for estimation of 109 
follicle density (14). In Copenhagen, 30 µm sections were stained with periodic-acid Schiff and 110 
Mayer´s reagents for further estimation of follicle density, 5 µm sections were processed for 111 
IHC staining.  112 
 113 
Immunohistochemical staining 114 
Sections were de-paraffinated in xylene, rehydrated in ethanol followed by antigen retrieval in 115 
either 10 mM sodium citrate, pH 6 or 10 mM Tris, pH 9. Retrieval was not required for zona 116 
pellucida protein 1 and 2 (ZP 1 and ZP 2) (15). Endogenous activity was inhibited using 1.5% 117 
peroxidase, followed by inhibition of nonspecific binding with 1% bovine serum albumin 118 
(BSA) (Sigma Aldrich, Copenhagen, Denmark). Sections were incubated with primary 119 
antibodies overnight at 4ºC except for ZP protein antibodies, which were incubated at 37°C for 120 
1 hour; details of antibodies and conditions are given in Supp. Table 1. Secondary antibody 121 
used was rabbit-anti-mouse-HRP (Dako, Glostrup, Denmark) and visualised with 3.3′-122 
diaminobenzidine tetrahydrochloride (DAB+ Substrate Chromogen System, Dako). Both 123 
Universal negative control serum® (BioCare Medical, CA, USA) and antibody dilution buffer 124 
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was used in place of primary antibody as negative controls and showed no staining (Supp. Fig. 125 
1). An Apop Tag Plus Peroxidase In Situ Apoptosis Detection Kit (Millipore, North Ryde, 126 
Australia) detecting apoptosis terminal deoxynucleotidyl transferase mediated dUTP Nick End 127 
Labeling (TUNEL) was also included. 128 
 129 
Follicle density 130 
Two methods were used to estimate the non-growing follicle density in the ovarian cortex. In 131 
Copenhagen,  the follicle density was estimated in 30 µm section using a mathematical model 132 
described by Schmidt and colleagues (16). In brief, this model was based on the fraction of 133 
sections, the mean primordial follicle diameter, and a correction factor (α) to account for the 134 
possibility of counting the same follicle more than once. Since the mean diameter of a 135 
primordial follicle is 44 µm (17) and the sections were 30 µm, there was a possibility to count 136 
the same follicle two or three times (16). In Edinburgh and Melbourne follicle density was 137 
measured in 5 µm sections by McLaughlin and colleagues (14). In brief, all tissues sections 138 
were examined for the presence of follicles. To avoid overcounting, follicles were only assessed 139 
when the nucleolus was observed. The follicle density was determined by dividing the total 140 
number of follicles in the biopsy  by the volume of tissue analyzed. To evaluate if the two 141 
methods of data collection were comparable a predictive model was used (14), which combine 142 
an age-related normative model for follicle population in the human ovary (18) and an age-143 
related normative model for the volume of the human ovary (19). Comparison of data obtained 144 
by the two methods used shows good agreement using the predictive model (14). 145 
 146 
Hormone assays  147 
Follicle fluid was aspirated using a 29 gauge syringe from small antral follicles (< 7.0 mm in 148 
diameter) during preparation of ovarian tissue for cryopreservation. Estradiol, testosterone, 149 
AMH, and inhibin-B concentrations were measured in follicle fluid (after appropriate dilution) 150 
using commercially available enzyme-linked immunosorbent assay (ELISA) kits. Estradiol and 151 
testosterone were measured with Nova Tech ELISA assays (DNOV003, DNOV002, Aalborg, 152 
Denmark), AMH and inhibin-B were measured with the UltraSensitive AMH/MIS and inhibin-153 
B ELISA kit (AL-105, AL-107, Ansh Labs, Webster, TX, USA) (20).  154 
 155 
Western blot 156 
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Western blot analyses were performed according to the manufacturer’s instructions (Invitrogen 157 
provided by Thermo Fischer, Hvidovre, Denmark). In brief, follicle fluid proteins were 158 
separated on a NuPAGE 4-12% Bis-Tris mini gel,  the proteins were subsequently blotted to a 159 
PVDF membrane (Thermo Fischer). The membrane was blocked in 5% skimmed milk and 160 
incubated with primary AMH antibody (AMH 39/48, Ansh Labs, TX, USA) overnight at 4oC 161 
and subsequently with secondary horseradish peroxidase-conjugated goat-anti-mouse antibody 162 
(Sigma Aldrich, Brøndby, Denmark) for 1 hour at room temperature. Signal was detected with 163 
PierceTM SuperSignal West Femto Substrate (Termo Fisher) and visualized with the DNR 164 
MicroChemi 4.2 bio-imaging system. We have previously validated the specificity of the AMH 165 
antibody used by blocking with surplus recombinant AMH, whereafter all AMH related bands 166 
disappeared (21). 167 
 168 
In vitro maturation of COCs 169 
Immature COCs from small antral follicles were collected from the surplus medulla tissue from 170 
one patient with mosaic TS and cultured in IVM medium (Origio, Måløv, Denmark) 171 
supplemented with FSH and LH and overlaid with liquid paraffin at 37oC in 5% CO2 humidified 172 
incubator for 48 hours as previously described (22). Cumulus cells were removed after 48 hours 173 
and the developmental stage of the denuded oocytes was evaluated using an inverted 174 
microscope and classified as either: ‘GV’, with a distinct germinal vesicle; ‘MI’, no germinal 175 
vesicle and no polar body; ‘MII’, one polar body extruded.     176 
 177 
Statistics 178 
Data on follicle density from the Danish girls below the age of 18 years have previously been 179 
published (11). An adjusted model including the new data has more normally distributed 180 
residuals (84% of a perfect Gaussian distribution), and hence is expected to have lower 181 
generalization error when assessing densities from subjects not used to derive the model. 182 
Statistical analysis was performed using GraphPad Prism 6.07 program (GraphPad Software, 183 
Inc., CA, USA) and Microsoft Excel version 14.6, with linear regression to evaluate follicle 184 
density against age and Mann-Whitney U-test to compare the hormone concentrations in 185 
follicular fluid. Significance was defined as p< 0.05. 186 
 187 
 188 
 189 
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Results 190 
A total of 15 girls and young women with TS aged 5.0-22.4 years old were included in this 191 
study. Three cases were postpubertal (i.e. >18 years old). Moreover, 11 of the 15 cases were 192 
diagnosed with mosaic TS.  193 
 194 
Follicle density 195 
Follicles were found in 60% (9/15) of the biopsies from TS ovaries - 8 girls with a mosaic 196 
karyotype and one 45,X, who was aged only 5 years and the youngest in the series (Table 1). 197 
No follicles were found in 2 patients with menopausal FSH levels (ages 14 and 17), in 2 with 198 
mildly elevated FSH levels (aged 17 and 22), nor in a further 2 patients (aged 8 and 14) with 199 
undetectable AMH levels.  All patients with follicles had a detectable AMH level and/or FSH 200 
<10I U/L (except one on whom no hormone data were available).   201 
While follicle density was below age-matched mean for most TS patients, it was within the 202 
95% CI for controls in 78% (7/9) of the cases, in 22% (2/9) it was below the 95% CI (Fig. 1). 203 
Including both TS patients with and without follicles (n=15), no correlation between follicle 204 
density and age was found (p>0.1). When follicle densities from the present study were 205 
combined with previously published TS data including both patients with and without follicles 206 
(n=23)  (8), no correlation between follicle density and age was found (p>0.1) (Fig. 1). The 207 
cortex tissues were fixed in either 4% paraformaldehyde or Bouins solution before hisological 208 
examination and theoretically this difference in fixation may impact the follicle densities, 209 
however we find this very unlikely.    210 
 211 
Follicle morphology and immunohistochemistry (IHC) 212 
Most (6/9) ovaries showed a high rate of abnormal follicle morphology. The follicle 213 
morphology of three subjects are illustrated in Fig. 2. The major abnormalities observed in 214 
primordial follicles were misshapen, vacuolated oocytes and an incomplete layer of granulosa 215 
cells surrounding the oocyte (Fig. 2A) leading to irregular oocyte shape and partial lack of 216 
connection to the basal lamina and stromal cells. This also manifested in di-oocytic follicles 217 
(Fig. 2B). In many follicles the granulosa cells were swollen and did not have the flattened 218 
appearance normally observed in primordial follicles. Nuclear material within some oocytes 219 
was diffuse or pale suggesting an absence of the germinal vesicle membrane (Fig. 2A). Empty 220 
and degenerating follicles were often seen (Fig. 2A,B,D). Granulosa cell invasion of the oocyte 221 
of primary follicles were occasionally seen (Fig. 2E) together with shrunken granulosa cells 222 
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and contracted ooplasm (Fig. 2F). In some subjects, normal morphology was detected in the 223 
majority of follicles (Fig 2G,H,I), as in control ovarian tissue. 224 
The presence of 6 granulosa cell or oocyte specific proteins (20,23) were detected by IHC in 225 
three TS ovaries (subjects 1, 6 and 12) and one age-matched control (Supp. Fig. 2). TUNEL 226 
staining (subject 8) showed some areas with healthy follicles (Supp. Fig. 3C), however there 227 
were other areas of poor stromal integrity with most follicles having only an occasional healthy 228 
granulosa cell and evidence of apoptosis in the oocyte (Supp. Fig. 3D). High levels of ZP 1 and 229 
2 staining were observed within the oocytes and scattered throughout the cortical stromal tissue, 230 
which may indicate residual ZP proteins from eliminated follicles and has been observed 231 
previously following xenografting of normal ovarian cortex (Gook, unpublished) (Supp. Fig 232 
3A,B). Normal very low levels of ZP 1 expression was detected in 43% (83/193) of the 233 
primordial follicles and was elevated in 57% (110/193), which suggests atresia. Normal ZP 2 234 
expression was detected in 23% (45/199) of the follicles. The proportion of morphologically 235 
normal follicles was estimated to be 7% from TUNEL staining. 236 
 237 
Hormone concentrations in follicle fluid  238 
Hormone concentrations were measured in 8 follicles obtained from two girls with mosaic TS 239 
(subject 4 and 12): none of the other girls had small antral follicles that could be aspirated. The 240 
mean diameter ±SEM of the follicles was 5.0 mm ±0.4 (range: 3.4-6.7 mm) and the mean 241 
concentrations in follicle fluids were: estradiol 19 ±9 nmol/L; testosterone 132 ±23 nmol/L; 242 
AMH 2,941 ± 587 ng/ml; and inhibin-B 81 ±15 ng/ml, respectively (Supp. Table 2; Fig. 3A). 243 
The concentrations of estrogen and testosterone in follicular fluid from girls with TS were 244 
significantly lower and AMH higher than the concentrations in follicular fluid from size-245 
matched (3.4-5.9 mm) follicles from age-matched controls (24) (p=0.036, 0.001, 0.005, 246 
respectively; Supp. Table 2). No differences in inhibin-B concentrations between TS and 247 
normal follicle fluids were found (p>0.1). All 6 follicle fluids from subject 12 was analysed 248 
with western blot detecting for AMH and compared to 6 follicle fluids obtained from control 249 
size matched follicles and no differences in AMH processing was detected (Fig. 3B).  250 
 251 
In vitro maturation of oocytes    252 
COCs (n=31) were cultured from one mosaic girl (subject 12). After 48 hours of culture, 6 had 253 
degenerated, 13 remain at the germinal vesicle (GV) stage, while 12 had resumed meiosis  (7 254 
at MI and 5 at the MII stage), resulting in a maturation rate of 16% and degeneration rate of 255 
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19%. Although this outcome is only from one patient, this is a lower maturation rate and higher 256 
degeneration rate than that previously reported by our group for COC from young women (<20 257 
years) with normal ovaries (55%, 4% respectively) (22).  258 
 259 
Discussion 260 
To our knowledge, this study is the first to characterize follicles and explore the IVM potential 261 
of oocytes from girls and young women with TS in comparison to age-matched controls. 262 
Follicles were detected in the ovarian cortex in 9 of 15 patients with TS, and the presence of 263 
follicles was associated with detectable serum AMH and normal FSH levels. Follicle density 264 
was within the 95% CI of normal age-matched girls and young women in 7 of these 9 patients. 265 
TS patients originated in Denmark, UK, and Australia, whereas all control patients were 266 
Danish, and we cannot rule out that the evaluated ovarian parameters would have been different 267 
in a cohort originated in UK or Australia, though we find it unlikely. All except one had mosaic 268 
TS, confirming observations from Borgström and colleauges (7) and consistent with women 269 
with this karyotype having a higher chance of conceiving (2,5,7,9). While follicles were 270 
detected in the youngest patient included, a 5-year-old with 45X karyotype, primordial follicle 271 
morphology was abnormal, with most follicles having an incomplete granulosa cell layer, 272 
oocyte vacuoles or collapse, or absent oocyte (empty follicles).  273 
 274 
The diversity of follicle morphology between patients further complicated the prediction of who 275 
may benefit from OTC. In some cases, follicle morphology was similar to normal whereas in 276 
others, a high proportion and range of abnormalities were seen. This is supported by increased 277 
expression of ZP proteins (normally very low in healthy primordial follicles and elevated in 278 
atretic follicles  (25)) and DNA fragmentation detected in one TS patient. This may indicate 279 
limited potential for later fertility in this TS patient. Empty follicles have been observed in 280 
human ovarian cortex cultured in the presence of an inhibitor of mTOR (26) and were detected 281 
in ovaries analysed in all 3 centres negating any effect of different fixation methods. However, 282 
all 6 glycoproteins related to oocyte growth and follicle health that were evaluated were 283 
detected, suggesting that at least a proportion of TS follicles may be normal and functional.  284 
 285 
From one 18-year-old girl with TS, immature COCs were aspirated and matured in vitro.  This 286 
demonstrates that TS oocytes can develop to the MII stage and may possess fertility potential. 287 
This is consistent with a case study that reported oocyte retrieval and maturation to MII in a 288 
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young woman with mosaic TS (27), with 65% of the oocytes obtained having a normal 289 
karyotype. While the karyotype was not assessed here, these findings suggest that immature 290 
oocytes can be collected from the medulla tissue in connection with OTC and that these oocytes 291 
could be an additional source for fertility preservation in mosaic TS, although the maturation 292 
rate appeared lower than with oocytes from normal women.  293 
 294 
We also identified that hormone concentrations in follicle fluid from small antral follicles from 295 
TS ovaries were strikingly different from the concentrations found in size-matched normal 296 
follicles, with low concentrations of estradiol and testosterone, and markedly higher AMH. 297 
Inhibin-B concentrations appeared normal. The low testosterone concentration may reflect 298 
abnormal theca cell function, and may impact follicle development including granulosa cell 299 
proliferation, which is reflected in the low estradiol concentrations. AMH is predominantly 300 
present during follicle development until follicular selection for dominance (20). There is a 301 
strong negative relationship between follicle fluid AMH and estradiol in normal women (28), 302 
which appears to be exaggerated in TS. These high AMH concentrations together with very low 303 
steroid concentration in TS follicles may reflect abnormal function of the somatic cells of the 304 
follicle, and additionally through impairment of the regulation of folliculogenesis, contribute to 305 
the accelerated follicle loss in TS confirmed here. Western blot was used to evaluate the 306 
processing of AMH in TS follicle fluids and non TS (normal) follicle fluids from size matched 307 
follicles. No difference in AMH processing was detected between TS and normal, suggesting 308 
that the processing of AMH in TS patients are similar to normal. 309 
  310 
Although it is now well recognized that transplanted frozen/thawed ovarian tissue can restore  311 
fertility no one has, to our knowledge,  transplanted ovarian tissue to a woman with TS, despite  312 
OTC  being reported (7–9,27,29,30). Thus, it remains to be demonstrated whether transplanted 313 
frozen/thawed ovarian tissue from TS girls/adolscents has the capacity to restore fertility. The 314 
rationale behind OTC in TS patients is different from other medical indications like 315 
chemotherapy. In case of cancer, the ovarian tissue has been exposed to no or a discrete injury 316 
before OTC. This contrast with TS ovarian tissue, which itself has a limited life expectancy and 317 
auto-grafted TS tissue will therefore have a limited survivability, why the benefit of OTC in TS 318 
patients may be limited. Further, maternal risks, including mortality during pregnancy in TS 319 
are very high, largely due to cardiovascular risks (9,10), which has to be taken into account 320 
when considering auto-grafting in TS patients. The cardiovascular risks may reflect the 321 
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underlying connective tissue abnormalities present in TS (31), which may also be relevant to 322 
the stromal tissue and somatic cells of the ovary. In vitro maturation and surrogacy may also be 323 
considered an option for TS patients. A recent review suggested that TS patients should be 324 
evaluated in early childhood to allow them to benefit from fertility preservation options (32), 325 
which is important to these patients and their parents (33).  326 
 327 
Conclusions 328 
The present analysis showed that even where follicles are present in girls with mosaic TS, many 329 
of these follicles may show abnormalites that are likely to limit their potential for later 330 
development and to support fertility. However, normal follicles were also present. Therefore, it 331 
appears reasonable to consider OTC for fertility preservation as an option for highly selected 332 
adolescent patients with mosaic TS where endocrine assessment does not indicate POI, and if 333 
other health issues do not preclude pregnancy. Oocytes from TS medulla tissue may also 334 
provide an additional fertility option. However, it is important to note that transplantation of 335 
frozen/thawed ovarian tissue has not yet been performed in women with TS, and it remains to 336 
be seen  whether the procedure can restore fertility.  337 
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 456 
Figure legends 457 
 458 
Fig. 1. Follicle density in normal ovaries (triangles) and in girls with TS (filled circles) plotted 459 
against age. Only TS tissues with follicles detected (9/15) are included. Previously published 460 
data on follicle density  in girls with TS (n=5) are included (8) (open circles).   461 
Fig. 2.  Ovarian morphology in tissue from 3 girls with TS. (A,B,C) Subject 8. (A) Primordial 462 
follicles with missing granulosa cells (arrows), some follicles had diffuse or pale nuclear 463 
material suggesting absence of germinal vesicle membrane (arrowheads); (B) fused follicles 464 
(arrows); (C) follicles with normal granulosa cells (arrows), scale bar: 100 µm. (D,E,F) Subject 465 
1. (D) Primordial follicles with collapsed oocytes (arrows) and empty follicle (arrowhead); (E) 466 
granulosa cell invasion of the oocyte of a primary follicle (arrow); (F) primary to secondary 467 
transition, shrunken granulosa cells and contracted ooplasm, scale bar: 50 µm. (G,H,I) Subject 468 
12. (G, H) Normal morphology in the majority of primordial follicles with flat granulosa cells 469 
(arrows) and  primary/intermediate follicles with cuboidal granulosa cells (arrow heads); (I) 470 
tertiary follicle, scale bar: 50 µm. 471 
Fig. 3. (A) Concentration of AMH and inhibin-B in follicle fluids (FF) (red circles) obtained 472 
from two girls with TS aged 13.5 and 17.8 years (subject 4 and 12) and in age-matched controls 473 
(grey triangles). AMH concentrations in these TS follicles are extremely high, whereas the 474 
inhibin-B concentration is similar to age-matched controls. (B) Detection of AMH in AMH 475 
standard (Std.) (lane 1), FF from TS patient subject 12 (lane 2-7), and in size matched follicles 476 
from different normal women (lane 8-13). Lane 7 was loaded with less FF than the remaining 477 
because the sample was used up, which explain the weaker/no bands seen. Arrows indicate 478 
AMH cleavage fragments. The blots show no difference in the composition of AMH forms in 479 
TS and normal FF. 480 
 Supp. Fig. 1. Negative controls. (A,B) TS Mosaic, 14.4 years; (C,D) TS Mosaic, 17.8 years; 481 
(E,F) Control, 10.5 years. (A,C,E) Primary antibody preplaced with antibody dilution buffer 482 
(1% BSA in PBS). (B,D,F) Primary antibody preplaced with Universal Negative Control 483 
serum®.  484 
Supp. Fig. 2. Expression of 6 proteins important for follicular growth: pro-region of Anti-485 
Müllerian hormone (proAMH), growth/differentiation factor 9 (GDF9), bone morphogenetic 486 
protein 15 (BMP15), insulin-like growth factor-binding protein 4 (IGF BPB4), pregnancy-487 
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associated plasma protein A (PAPP-A), stanniocalcin 2 (STC2) in ovarian cortical tissue from 488 
three TS patients aged 5.0, 14.4 and 17.8 years and one control aged 10.5 years.  489 
Supp Fig. 3. Expression of zona pellucida proteins (ZP 1 and ZP 2) and apoptotic marker 490 
(TUNEL) in a TS ovary aged 14.8 years (subject 8). (A) ZP 1 protein was detected in a pattern 491 
resembling normal follicles (arrows) and in some follicles aberrant staining was observed 492 
(arrowhead). (B) Low expression of ZP 2 was observed in healthy looking primordial follicles 493 
(arrows), while an apparent increased staining was observed in other follicles. (C) Stromal cells, 494 
oocytes (arrows) and granulosa cells in this area were predominantly TUNEL negative (green 495 
staining), though TUNEL was observed in some granulosa cells (arrowhead). (D) Single 496 
stranded DNA (TUNEL positive) was in other areas observed in some oocytes and granulosa 497 
cells (arrows). Cells of the stromal tissue also had evidence of single strand DNA (weak brown 498 
staining). Dotted boxes indicate enlarged areas. Scale bar: 100 µm and 50 µm on 499 
magnifications.  500 
